NCT05363488 2023-04-03Retrospective Observational Research Study to Describe the Real World Use of Bosutinib in a Single Centre in ScotlandPfizerCompleted17 enrolled
NCT02130557 2021-05-18A Multicenter Phase 3, Open-Label Study of Bosutinib Versus Imatinib in Adult Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous LeukemiaPfizerPhase 3 Completed536 enrolled 24 charts 1 FDA
NCT00261846 2017-07-27Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive LeukemiasPfizerPhase 2 Completed571 enrolled 48 charts